Epithelial membrane protein-2 (EMP2) and proliferative vitreoretinopathy (PVR)

Details for Australian Patent Application No. 2010321885 (hide)

Owner The Regents of The University of California The United States Government, as represented by The Department of Veterans Affairs

Inventors Gordon, Lynn K.; Morales, Shawn A.; Telander, David; Braun, Jonathan

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-A-2010321885

PCT Pub. Number WO2011/063161

Priority 61/263,228 20.11.09 US

Filing date 18 November 2010

Wipo publication date 26 May 2011

International Classifications

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 27/00 Drugs for disorders of the senses

A61P 27/02 Drugs for disorders of the senses

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/063161 Priority application(s): WO2011/063161

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010321895-A reactive solution of polymerizable polymer comprising polymerizable reactive functionalities, process and compositions thereof

2010321884-Methods for improving oral delivery